New Paradigms and Landscape
Changes in Atrial Fibrillation

WebCAST

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Program Medium:

Internet-based program

Method of Physician Participation Utilized in Learning Process:

There are no fees for participating and receiving CME credit for this activity. During the period April 1, 2010 through April1, 2012, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) register and complete the evaluation form; and 4) print out your CME certificate.

Estimated Time to Complete Educational Activity:

Three hours

Course Overview:

In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance strategies for stroke prevention in patients with atrial fibrillation, and review evidence-based approaches to managing complications across the spectrum of atrial fibrillation, based on findings reported in the latest clinical research.

Release Date:

April 1, 2010

Expiration Date:

April 1, 2012

Intended Audience:

• Cardiologists
• Preventive cardiologists
• Cardiovascular electrophysiologists
• Neurovascular specialists
• Vascular biologists
• Anticoagulation experts
• Heart failure specialists
• Coronary care unit (CCU) specialists and directors
• Program directors, cardiovascular medicine
• Fellows in cardiovascular medicine
• Clinical pharmacists and pharmacologists
• Pharmacy directors (cardiovascular medicine)
• Investigators and clinical trial specialists
• Cardiovascular nurses

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant
from Boehringer Ingelheim.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Peter Libby, MD, FACC - Program Chairman and Moderator
Chief, Cardiovascular Medicine
Brigham and Women’s Hospital
Mallinckrodt Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Nothing to disclose

Jonathan L. Halperin, MD
Mount Sinai School of Medicine
Director, Clinical Cardiology Service
The Zena and Michael A. Wiener Cardiovascular Institute
The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health
New York, New York

Consultant: Astellas Pharma, U.S., Bayer HealthCare, Biotronik, Inc, Boehringer-Ingelheim, Daiichi-Sankyo Pharma, Johnson & Johnson, Portola Pharmaceuticals, Sanofi-Aventis


Elaine M. Hylek, MD, MPH
Associate Professor of Medicine
Department of Medicine
Boston University Medical Center
Boston, Massachusetts

Advisory Boards: Bristol-Myers Squibb, sanofi-aventis, Boehringer-Ingelheim


Jeffrey I. Weitz, MD, FRCP, FACP
Professor of Medicine and Biochemistry
McMaster University
Director, Henderson Research Center
Canada Research Chair in Thrombosis
Heart and Stroke Foundation
J.F. Mustard Chair in Cardiovascular Research
Ontario, Canada

Honoraria: Bristol-Myers Squibb, Daiichi-Sankyo, Takeda
Consultant: Boehringer-Ingelheim, sanofi-aventis, The Medicines Company, Bayer, Bristol-Myers Squibb, Eisai, Daiichi-Sankyo, Takeda

Program Managers and Web Editor Disclosure:

Program Managers Milo Falcon and Gideon Bosker have nothing to disclose.

Program Reviewers Denise Leary and Richard Aghababian, MD have nothing to disclose.

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn about advances in oral anticoagulation based on new mechanisms involving inhibition of the coagulation cascade and possible implications for prophylaxis of stroke and arterial thromboembolism in the setting of atrial fibrillation.
• Learn about the mechanisms involved in thromboembolic prevention and the rationale for identifying agents with predictable anticoagulation, in the absence of clinical monitoring.
• Learn about current ACCP, ACC, AHA, and AAN guidelines for stroke prevention in the setting of AF.
• Learn about novel, evidence-based approaches for residual risk reduction and secondary prevention of adverse thromboembolic events (stroke) in the setting of atrial fibrillation, and related conditions.
• Learn how to apply landmark clinical trials focusing on thromboembolic risk prevention in patients with ACS and atrial fibrillation.
• Learn about the implications of employing oral, non-monitored anticoagulants with clinical effects mediated by novel mechanisms of action.
• Learn to risk stratify patients, assess their likelihood for incurring stroke in the setting of AF and be aware of current and evolving prophylaxis measures that can reduce the incidence of stroke.
  

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to printout the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

• We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
• For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
• We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
• If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
• You should check this privacy policy periodically to see whether we have made any changes.
  

Disclaimer:

Copyright © 2010 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2010 All rights reserved